Nov. 14 at 5:34 PM
JPMorgan cut
$IHS to Underweight from Overweight and lowered the target to
$6 (from
$8). Despite the stock being up 120% this year, JPM says growth in Nigeria/Africa looks modest and other tower stocks offer more upside. Long-term outlook remains uncertain.